318,135
Levothyroxine prescriptions in Utah, 2023
20 of 49
Utah cities where it's the #1 prescribed drug
#2
Statewide rank, behind only Atorvastatin
Nationally, the most prescribed drug in Medicare Part D is almost always a cholesterol medication. Atorvastatin, specifically. It sits at #1 in state after state, which makes sense, cardiovascular disease is the leading cause of death in the U.S., and statins are one of the most commonly prescribed tools to manage it.
Utah is different. In 20 of the 49 cities with meaningful Medicare prescribing data, Levothyroxine, a thyroid medication, knocks Atorvastatin out of the top spot. Sandy, Orem, Provo, Salem, Moab, and a dozen others all show the same pattern.
That's unusual enough to be worth talking about.
What Levothyroxine does
Levothyroxine is a synthetic version of the thyroid hormone your body normally produces. It's prescribed when your thyroid gland isn't producing enough hormone on its own, a condition called hypothyroidism. Most people who have it take one small pill every morning, usually for the rest of their lives.
The symptoms of an underactive thyroid are easy to miss, especially in older adults. Fatigue that seems like normal aging. Weight gain. Feeling cold all the time. Constipation. Brain fog. A lot of people go years without knowing their thyroid is the problem.
That's part of why catching it matters, and why asking about thyroid screening when you turn 65 is worth doing.
The Utah angle
There isn't a single confirmed reason why thyroid prescriptions run higher in Utah than in many other states, but there are a few threads that researchers have pointed to over the years.
One is geography. Utah sits in a region that historically had iodine-poor soil. Iodine is the mineral your thyroid needs to make hormones, and inland areas far from the ocean tend to have less of it in local food and water. Before the widespread use of iodized salt, thyroid disorders were much more common in inland states, a region old textbooks actually called the "goiter belt," which ran from the Great Lakes down through Utah and the Mountain West.
Modern iodized salt has narrowed that gap, but the pattern may have lingered through generations of people who developed thyroid issues earlier in life and are now in the Medicare population.
A second factor is the structure of Utah's healthcare system. Utah has a relatively high rate of primary care physicians per capita in certain areas, and thyroid screening is a standard part of routine bloodwork. More screening means more diagnoses.
Utah Cities Where Levothyroxine Has the Highest Share of All Prescriptions
Moab leads all
Utah cities with Levothyroxine making up 6.4% of all Medicare prescriptions. That's one in every 16 prescriptions being a thyroid medication. Park City and Orem are close behind at 5.2% and 5.1% respectively.
What this means if you're turning 65
Thyroid disease is more common in women than men, and it becomes more common with age. By some estimates, up to 20% of women over 60 have some degree of thyroid dysfunction, much of it undiagnosed.
The standard test is a simple blood draw called a TSH (thyroid-stimulating hormone) test. It's included in most routine labs. If you haven't had one recently, it's a reasonable thing to ask your doctor about, especially if you've been feeling more tired or foggy than usual and can't explain why.
If you already take Levothyroxine, a few things are worth knowing as you head into Medicare. First, the drug itself is inexpensive, about $20 per prescription on average, so it won't put much pressure on your Part D plan costs. Second, dosing matters a lot. Too little and you're still symptomatic. Too much and you risk bone loss and heart problems. Regular monitoring is part of managing it well.
One more thing worth knowing
Levothyroxine is one of those medications where generics and brand names actually do matter a little. Most pharmacists and doctors will tell you that switching between different versions, even if they're all technically the same drug, can throw off your levels. If you're stable on what you're taking, try to stay consistent. If you move or switch pharmacies, tell them you're on thyroid medication and want to stay on the same formulation.
It sounds like a small thing. For most medications, it is. For thyroid medication specifically, the margin for variation is tighter than you'd expect.
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2023. Utah city-level data. Cities with 500+ prescriber records included.
Sources
- CMS, 2026 Medicare Parts A & B Premiums and Deductibles Fact Sheet (Nov 14, 2025): Part B standard premium $202.90; Part B deductible $283; Part A inpatient hospital deductible $1,736.
- SSA, Social Security Announces 2.8 Percent Benefit Increase for 2026 (Oct 24, 2025) and 2026 COLA Fact Sheet: 2.8% COLA; average retired worker benefit rises from $2,015 to $2,071.
- CMS, Final CY 2026 Part D Redesign Program Instructions: $2,100 annual Part D out-of-pocket cap.
- 2026 IRMAA brackets (single $109,000 / joint $218,000 starting thresholds); Part B IRMAA total ranges $284.10 to $689.90/month; Part D IRMAA surcharges $14.50 to $91.00/month. See CMS 2026 Fact Sheet (linked above) and the Kiplinger 2026 IRMAA brackets summary.
- CMS, Medicare Part D Prescribers by Geography and Drug: state and local prescription totals and costs (2023 release).
- CMS, Medicare Care Compare: nursing home, hospital, dialysis, and home health quality ratings.
- Utah Department of Health and Human Services, dhhs.utah.gov: Utah-specific provider and health workforce data.
A note on this data: All figures come from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescribers by Geography & Drug dataset, 2023. This data covers Medicare Part D (prescription drug coverage) only and does not represent commercial insurance, Medicaid, or cash-pay prescriptions. Suppressed values (fewer than 11 beneficiaries) are excluded from totals.
This article is for educational purposes only. Nothing here is medical advice. Talk to your doctor before making any decisions about your medications or treatment. This content is not connected with or endorsed by the U.S. Government or the federal Medicare program.